Linda Rosenberg, | |
31 S Fullerton Ave, Montclair, NJ 07042-3455 | |
(973) 783-3030 | |
Not Available |
Full Name | Linda Rosenberg |
---|---|
Gender | Female |
Speciality | Counselor - Professional |
Location | 31 S Fullerton Ave, Montclair, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194194795 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 46TR00353900 (New Jersey) | Secondary |
101YP2500X | Counselor - Professional | 37PC00553200 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Linda Rosenberg, 31 S Fullerton Ave, Montclair, NJ 07042-3455 Ph: (973) 783-3030 | Linda Rosenberg, 31 S Fullerton Ave, Montclair, NJ 07042-3455 Ph: (973) 783-3030 |
News Archive
A type of immune cell widely believed to exacerbate chronic adult brain diseases, such as Alzheimer's disease and multiple sclerosis (MS), can actually protect the brain from traumatic brain injury (TBI) and may slow the progression of neurodegenerative diseases, according to Cleveland Clinic research published today in the online journal Nature Communications.
Roll Call: "Senate Majority Leader Harry Reid (D-Nev.) scored a major victory Saturday night by persuading all 60 members of the Democratic Conference to vote to bring his $848 billion health care reform bill up for debate.
...characterized by malaise, fatigue and depression, and often mistaken for poor performance, according to a study by Ann Barr, Ph.D., and Mary Barbe, Ph.D., at Temple University's College of Health Professions.
Former American Idol finalist Danny Gokey and The Clorox Company have teamed up to launch I Don't Want to Miss…, a national contest designed to get teens and their teachers involved in flu prevention.
In its review of the BLA, the FDA stated the T-DM1 trials did not meet the standard for accelerated approval because all available treatment choices approved for metastatic breast cancer, regardless of HER2 status, had not been exhausted in the study population.
› Verified 5 days ago